Safety Risk Management: A Focus on EU RMPs and US REMS

Back to Agenda

Session 9: Development of the Risk Management Strategy and Authoring Risk Management Documents

Session Chair(s)

Carla Barrett, PharmD

Vice President, Global Risk Management

Novavax, United States

This session will provide details on how to develop the risk management strategy by defining a product’s risks to patients, developing a plan for pharmacovigilance, developing a plan for risk minimization, determining how to implement the actions, and addressing regional variations of risk management strategies. This session will also describe the process for authoring Risk Management Documents such as EU-REMPs and REMS, as well as related safety documents.

Have an account?

Safety Risk Management: A Focus on EU RMPs and US REMS

Session 9: Development of the Risk Management Strategy and Authoring Risk Management Documents

Session Chair(s)

Carla Barrett, PharmD

Be informed and stay engaged.